The Economic Impact Associated With Cerebrovascular Events Related to Non-Valvular Atrial Fibrillation (NVAF) in Italy: The Role of Apixaban

Farmeconomia. Health economics and therapeutic pathways
doi 10.7175/fe.v15i1s.972
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Seed SRL

Related search

Estimating the Lifetime Clinical Risk/Benefits of Apixaban Versus Edoxaban in Non-Valvular Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Thromboembolic Events in Paroxysmal vs. Permanent Non-Valvular Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

Cost-Effectiveness of Apixaban for Stroke Prevention in Non-Valvular Atrial Fibrillation in Saudi Arabia

Annals of Saudi Medicine
Medicine
2019English

Clinical Epidemiology of Atrial Fibrillation and Related Cerebrovascular Events in the United States

Neurologist
MedicineNeurology
2008English

The Thrombogenic Role of Platelets in Valvular Atrial Fibrillation

2012English

Long-Term Vitamin K Antagonists Treatment Patterns of Non-Valvular Atrial Fibrillation (NVAF): A Population-Based Cohort Study

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2016English

Pcv84 - Cost-Effectiveness Analysis of Apixaban Versus Edoxaban for Stroke Prevention in Non-Valvular Atrial Fibrillation Spanish Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcv116 - Discontinuation and Health Care Resource Utilisation in Non-Valvular Atrial Fibrillation Patients Treated With Apixaban or Warfarin in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Prognostic Impact of CHA2DS2VASC and Renal Dysfunction in Non Valvular Atrial Fibrillation Patients: Which Is the Best Equation to Stratify Risk of Future Events?

Cardiologia Croatica
Cardiovascular MedicineCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy